Concepedia

Author

Jin Cao

Amgen (United States)

Also Known As

Jin Cao

14

Publications

2.3K

Citations

8

H-Index

31

Concepts

All Affiliations

Amgen (United States)
JC

About

Jin Cao is an author at Amgen (United States) specializing in medicine, scleroderma, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

896

2

Cell Biology

2

2

805

3

Public Health

1

1

91

4

Endocrinology

1

1

773

5

Epidemiology

1

1

91

Jin Cao

×

6

Publications

2.3K

Citations

6

H-Index

YearCitations

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

Xiaodong Li, Michael S. Ominsky, Qing‐Tian Niu,

Journal of Bone and Mineral Research

2008

932

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

Xiaodong Li, Michael S. Ominsky, Kelly Warmington,

Journal of Bone and Mineral Research

2008

773

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

Michael S. Ominsky, Fay Vlasseros, Jacquelin Jolette,

Journal of Bone and Mineral Research

2010

410

Temporal trends in cross-country inequalities of stroke and subtypes burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021

Zeyu Luo, Shiyi Shan, Jin Cao,

EClinicalMedicine

2024

91

Sclerostin expression is induced by BMPs in human Saos-2 osteosarcoma cells but not via direct effects on the sclerostin gene promoter or ECR5 element

Longchuan Yu, Marissa van der Valk, Jin Cao,

Bone

2011

32

Inequalities in disease burden and care quality of chronic obstructive pulmonary disease, 1990–2021: Findings from the Global Burden of Disease Study 2021

Lingzi Yao, Jin Cao, Siqing Cheng,

Journal of Global Health

2024

12

Page 1